Sequence Bio
NL - St. John'sBiotechnology
Focus: Sequence Bio is a genomic analysis company focused on identifying drug targets for oncology applications, operating from St. John's, Newfoundland and Labrador. The company leverages genomic data to support early-stage drug discovery and development.
Profile data last refreshed 1h ago · AI intelligence enriched 3w ago
Open Jobs
2+1 this month
Stable — net +1 jobs in 30d
1 added, 0 removed. Backfill posture.
Should You Work at Sequence Bio?
AI assessmentSequence Bio is an early-stage genomic oncology platform play suitable only for risk-tolerant scientists seeking hands-on R&D roles; limited hiring and missing financial data suggest the company is still in stealth or pre-scaling phase.
Why Work Here
- Opportunity to work in cutting-edge genomic analysis for oncology drug discovery, a high-priority therapeutic area
Data completeness
2/9 — Limited
Company HealthSolid
Pipeline
Early-stage
0 total
LOE Risk
Protected
No near-term cliffs
Hiring
Stable
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Help build intelligence for Sequence Bio
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.